Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hemophilia
100%
Severe Haemophilia A
52%
Indonesia
40%
Pediatric
29%
Indonesian Version
25%
Indonesian
21%
Low-dose Prophylaxis
19%
On Demand
18%
Jakarta
17%
Dose Factor
17%
Single-center Experience
17%
Asia
17%
Joint Bleeding
16%
Arthropathy
16%
Coagulation
14%
Bleeding Disorders
13%
Factor VIII Inhibitor
13%
Tertiary Prophylaxis
12%
Indonesian Adolescents
12%
Ultrasound
11%
Moderate Haemophilia
11%
On-demand Treatment
10%
High Risk
10%
Population Pharmacokinetics (PopPK)
10%
Mild Haemophilia
10%
Test Validity
10%
Emicizumab
9%
Clinical Characteristics
9%
Haemophilia Treatment Centre
9%
Haemophilia Care
9%
Hemophilia Joint Health Score
9%
Transfusion
9%
Pharmacokinetic Profile
9%
Factor VIII Prophylaxis
8%
Hemosiderin Deposition
8%
Imaging Sequences
8%
Plasma-derived
8%
Joint Association
8%
Gradient Echo
8%
D-dimer
8%
Pharmacokinetic Model
8%
Acute Leukemia
8%
Hemostatic Abnormalities
8%
Pada
8%
Urinary Tract Infection
8%
Children with Thalassemia
8%
Late-onset
8%
Coagulation System
8%
Learning Intervention
8%
Epilepsy
8%
Medicine and Dentistry
Haemophilia A
96%
Pediatrics
31%
Low Drug Dose
17%
Bleeding Disorder
13%
Blood Clotting Factor 8 Inhibitor
13%
Blood Clotting Factor 8
12%
Recurrent Disease
11%
Oncology
11%
Blood Clotting
10%
Emicizumab
9%
Quality of Life
9%
Magnetic Resonance Imaging
9%
Echography
9%
Prevalence
8%
Arthropathy
8%
Hemosiderin
8%
Posttransfusion Hepatitis
8%
Nucleic Acid
8%
Ankle Joint
8%
Hemostat
8%
Iron Overload
8%
Thalassemia Major
8%
Non-Hodgkin Lymphoma
8%
Hepatitis C
8%
Blood Donor
8%
Pediatric Hematology
8%
Cerebral Hemorrhage
8%
Angiosarcoma
8%
Urinary Tract Infection
8%
Neonatal Sepsis
8%
Musculoskeletal System
8%
Musculoskeletal Function
8%
Purpura
8%
Antimicrobial Agent
8%
Adolescence
8%
Gene Mutation
8%
Acute Leukemia
8%
Dimer
8%
D-Dimer
8%
Partial Thromboplastin Time
7%
Sepsis
7%
Bleeding
6%
Cross Sectional Study
6%
Urine Culture
6%
Blood Transfusion
5%
Blood Clotting Factor Concentrate
5%
Hemarthrosis
5%
Nursing and Health Professions
Haemophilia A
42%
Youth
17%
Pediatrics
12%
Overall Survival
9%
Depression Inventory
8%
Epilepsy
8%
Blood Clotting Factor 8 Inhibitor
8%
Urinary Tract Infection
8%
Clinical Practice
8%
Newborn Sepsis
8%
Rheumatic Disease
8%
Antimicrobial Agent
8%
Pediatric Quality of Life Inventory
8%
Dimer
8%
D Dimer
8%
Nonhodgkin Lymphoma
8%
Acute Leukemia
8%
Congenital Heart Disease
8%
Neutrophil Lymphocyte Ratio
8%
Open Heart Surgery
8%
Musculoskeletal System
8%
Forward Heart Failure
8%
Retinoblastoma
8%
Survival Prediction
8%
Inflammation
8%
Prevalence
7%
Cross-Sectional Study
7%
Sepsis
7%
Pediatrician
7%
Urine Culture
6%
